Evolution of functional antibodies following acute Epstein-Barr virus infection

CB Karsten, YC Bartsch, SA Shin, MD Slein… - PLoS …, 2022 - journals.plos.org
While Epstein-Barr virus causes mostly asymptomatic infection, associated malignancies,
and autoimmune and lymphoproliferative diseases occur. To dissect the evolution of …

Immunization of mice with virus-like vesicles of Kaposi Sarcoma-associated herpesvirus reveals a role for antibodies targeting ORF4 in activating complement …

AK Lam, R Roshan, W Miley, N Labo, J Zhen… - Journal of …, 2023 - Am Soc Microbiol
Infection by Kaposi sarcoma-associated herpesvirus (KSHV) can cause severe
consequences, such as cancers and lymphoproliferative diseases. Whole inactivated …

Epstein–Barr virus (EBV) antibody changes over time in a general population cohort in rural Uganda, 1992–2008

KR Sabourin, J Mugisha, G Asiki, A Nalwoga… - Infectious Agents and …, 2023 - Springer
Abstract Background Epstein–Barr virus (EBV) infection is ubiquitous and in sub-Saharan
Africa, occurs early in life. In a population-based rural African cohort, we leveraged historical …

Seroprevalence and characterization of Epstein-Barr virus exposure among paediatric population

P Garg, M Matlani, S Kumar, D Nair - Indian Journal of Medical Microbiology, 2024 - Elsevier
Abstract The study explored Epstein Barr Virus (EBV) exposure in 244 children using EBV-
specific serology. Seroprevalence of EBV was 75–80%. Past infection and primary infection …

Immunogenicity and protection mediated by next-generation EBV gH/gL vaccines in non-human primate and humanized mouse models of infection

K Edwards - 2024 - search.proquest.com
Abstract Epstein Barr Virus (EBV) is an orally transmitted, γ-herpesvirus infecting 90% of
adults worldwide. Infection is associated with various cancers and development of multiple …

[图书][B] Novel strategies for prophylactic viral vaccines enabled by lipid nanoparticle technology

AKS Lam - 2022 - search.proquest.com
Lipid nanoparticles (LNPs) are at the forefront of scientific thought due to the SARS-CoV-2
pandemic. While mRNA-LNPs have been studied for years, there is still much to be learned …